1,4-dihydroxy quininib modulates the secretome of uveal melanoma tumour explants and a marker of oxidative phosphorylation in a metastatic xenograft model

Overview of attention for article published in Frontiers in Medicine, January 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 3 news outlets
blogs: 1 blog

twitter: 20 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 6 Mendeley

Summary News Blogs X Dimensions citations

So far, Altmetric has seen 21 X posts from 20 X users, with an upper bound of 223,836 followers.

RT @medical_xpress: New tools to manage rare #eye cancer @ucddublin https://t.co/Luwe6PDe89 https://t.co/BlFamFxIUE

10 Apr 2023

Reply Repost Favourite

1,4-dihydroxy quininib modulates the secretome of uveal melanoma tumour explants and a marker of oxidative phosphorylation in a metastatic xenograft model https://t.co/r3jDRq7GBs

13 Feb 2023

Reply Repost Favourite

RT @medical_xpress: New tools to manage rare #eye cancer @ucddublin https://t.co/Luwe6PDe89 https://t.co/BlFamFxIUE

13 Feb 2023

Reply Repost Favourite

RT @medical_xpress: New tools to manage rare #eye cancer @ucddublin https://t.co/Luwe6PDe89 https://t.co/BlFamFxIUE

03 Feb 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 17 additional X posts.